Safety Study Extension of Iloprost Power 15 in Pulmonary Arterial Hypertension
Public ClinicalTrials.gov record NCT00709098. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Double-blind, Randomized Study Comparing the Safety and Tolerability of Iloprost Inhalation Solution Delivered by I-neb Utilizing Power Disc-15 and Power Disc-6 in Patients With Symptomatic Pulmonary Arterial Hypertension
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Patients with symptomatic idiopathic (IPAH) or familial (FPAH) pulmonary arterial hypertension in New York Heart Association (NYHA) class II to IV , naive to PAH treatment or currently being treated with a stable dose of either bosentan or sildenafil and who complete PROWESS 15 will be enrolled in the PROWESS 15 Extension study. This is a double-blind (12 week), randomized study to compare the safety and tolerability of inhaled iloprost power disc-15 and power disc-6 in patients with symptomatic pulmonary arterial hypertension (PAH). After completion of the double blind period, patients will be entered in the open label period using iloprost power disc-15.
Study identification
- NCT ID
- NCT00709098
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 49 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 2008 (Type not available)
- Primary completion
- Jun 2010 (Actual)
- Completion
- Jun 2010 (Actual)
- Last update posted
- Sep 28, 2015
2008 – 2010
United States locations
- U.S. sites
- 32
- U.S. states
- 22
- U.S. cities
- 31
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| UCSD Medical Center | La Jolla | California | 92037 | — |
| UC Davis Medical Center | Sacramento | California | 95817 | — |
| Liu Center for Pulmonary Hypertension - LA Biomedical Research Institute at Harbor-UCLA | Torrance | California | 90502 | — |
| Lung Health & Sleep Enhancement Center, LLC | Newark | Delaware | 19713 | — |
| University of Florida | Gainesville | Florida | 32610 | — |
| Pulmonary & Critical Care of Atlanta | Atlanta | Georgia | 30342 | — |
| Atlanta Institute for Medical Research | Decatur | Georgia | 30033 | — |
| University of Iowa Hospitals and Clinics | Iowa City | Iowa | 52242 | — |
| Mercy Hospital | Iowa City | Iowa | 52245 | — |
| Kentuckiana Pulmonary Associates | Louisville | Kentucky | 40202 | — |
| LSU Health Sciences Center | New Orleans | Louisiana | 70112 | — |
| University of Maryland Medical Center | Baltimore | Maryland | 21201 | — |
| University of Nebraska Medical Center | Omaha | Nebraska | 68198 | — |
| Newark Beth Israel Medical Center | Newark | New Jersey | 07112 | — |
| Winthrop University Hospital | Mineola | New York | 11501 | — |
| University of North Carolina | Chapel Hill | North Carolina | 27599-7020 | — |
| The Lindner Clinical Trial Center | Cincinnati | Ohio | 45219 | — |
| The Ohio State University Medical Center | Columbus | Ohio | 43221 | — |
| Legacy Health System | Portland | Oregon | 97210 | — |
| Temple University Hospital | Philadelphia | Pennsylvania | 19140 | — |
| Allegheny General Hospital | Pittsburgh | Pennsylvania | 15212 | — |
| Rhode Island Hospital | Providence | Rhode Island | 02903 | — |
| Lexington Pulmonary & Critical Care | Lexington | South Carolina | 29072 | — |
| UT Southwestern Medical Center Heart Lung and Vacular Center | Dallas | Texas | 75390-8550 | — |
| University of Texas Medical School | Houston | Texas | 77030 | — |
| Central Utah Clinic, P.C. | American Fork | Utah | 84003 | — |
| Intermountain Medical Center | Murray | Utah | 84157 | — |
| University of Virginia | Charlottesville | Virginia | 22908 | — |
| Sentara Hospitals T/A Sentara Cardiovascular Research Institute | Norfolk | Virginia | 23507 | — |
| Spokane Respiratory Consultants | Spokane | Washington | 99204 | — |
| UW Hospital & Clinics | Madison | Wisconsin | 53792 | — |
| Comprehensive Cardiovascular Care LLP | Milwaukee | Wisconsin | 53215 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00709098, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 28, 2015 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00709098 live on ClinicalTrials.gov.